Jinan Kangyue Qiming Investment Partnership (Limited Partnership) agreed to acquire 7.4% stake in Chengdu Kanghua Biological Products Co., Ltd. (SZSE:300841) from Aokang Group Co., Ltd. and Wang Zhentao for approximately CNY550 million on August 24, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
50.64 CNY | -1.19% |
|
-5.22% | -34.69% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.69% | 924M | |
+2.99% | 95.18B | |
-4.34% | 37.55B | |
-10.41% | 33.75B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B |
- Stock Market
- Equities
- 300841 Stock
- News Chengdu Kanghua Biological Products Co., Ltd.
- Jinan Kangyue Qiming Investment Partnership (Limited Partnership) agreed to acquire 7.4% stake in Chengdu Kanghua Biological Products Co., Ltd. from Aokang Group Co., Ltd. and Wang Zhentao for approximately CNY550 million.